A further analysis of the use of cytomegalovirus immune globulin in orthotopic liver transplant patients at risk for primary infection

Transplantation Proceedings

Volumn 26, Issue 5 SUPPL. 1, 1994, Pages 23-27

  Snydman, D R ^a   Werner, B G ^a   Dougherty, N N ^a   Griffith, J ^a   Rohrer, R H ^a   Freeman, R ^a   Jenkins, R ^a   Lewis, W D ^a   O'Rourke, E ^a   Fawaz, K ^a   Hoffman, M A ^a   Kaplan, M ^a   Barefoot, L ^a   Rubin, R H ^a   Dienstag, J L ^a   Doran, M ^a   Vacanti, J ^a   Hammer, S ^a   Martin, M ^a  

^a TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZATHIOPRINE; CYCLOSPORIN; CYTOMEGALOVIRUS ANTIBODY; GANCICLOVIR; HYPERIMMUNE GLOBULIN; IMMUNOSUPPRESSIVE AGENT; OKT 3; PREDNISONE; STEROID; TACROLIMUS; VIRUS ANTIBODY;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; CONFERENCE PAPER; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE SEVERITY; GRAFT REJECTION; GRAFT SURVIVAL; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INFECTION PREVENTION; INFECTION RISK; INTRAVENOUS DRUG ADMINISTRATION; LIVER TRANSPLANTATION; MULTICENTER STUDY; ORGAN TRANSPLANTATION; PRIORITY JOURNAL; SURVIVAL RATE; VIRUS ISOLATION;

ACYCLOVIR; ADULT; BOSTON; CANDIDIASIS; CHILD; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; FEMALE; GANCICLOVIR; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; IMMUNOSUPPRESSIVE AGENTS; LIVER TRANSPLANTATION; MALE; MUROMONAB-CD3; OPPORTUNISTIC INFECTIONS; PLACEBOS; PNEUMONIA, VIRAL; RISK FACTORS; TREATMENT OUTCOME;

EID: 0027949055     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (0)